Feasibility of HIV point-of-care tests for resource-limited settings: Challenges and solutions

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Stevens, Wendy ^a,b   Gous, Natasha ^a   Ford, Nathan ^c   Scott, Lesley E ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Anti retroviral therapy; CD4; Challenges; HIV; Implementation; Point of care; Viral load

Indexed keywords

BLOOD CHEMISTRY; FEASIBILITY STUDY; HEALTH CARE PLANNING; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL EDUCATION; NON COMMUNICABLE DISEASE; POINT OF CARE TESTING; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; REVIEW; DEVELOPING COUNTRY; POINT OF CARE SYSTEM; PROCEDURES; STANDARDS; VIROLOGY; VIRUS LOAD;

DEVELOPING COUNTRIES; FEASIBILITY STUDIES; HIV INFECTIONS; HUMANS; POINT-OF-CARE SYSTEMS; VIRAL LOAD;

EID: 84906857697     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0173-7     Document Type: Review

References (61)

1. UNAIDS: Global Report. UNAIDS Report on the global AIDS epidemic 2013, www.unaids.org/en/resources/campaigns/globalreport2013/globalreport/
2. UNAIDS: Global Report. UNAIDS Report on the global AIDS epidemic 2012, http://www.unaids.org/en/resources/publications/2012/name,76121,en.asp
3. World Health Organization: Scaling up antiretroviral therapy in resource limited settings. Guidelines for a public health approach 2002, http://data.unaids.org/publications/IRC-pub01/jc354-scalingupguidelinesdoc_en.pdf
4. World Health Organization: Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach 2010, http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf
5. World Health Organization: Consolidated guidelines on the use of anti-retrovirals for treating and preventing HIV infection: Recommendations for a public health approach 2013. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf?ua=1
6. De Cock KM, El-Sadr WM. Perspective: When to start ART in Africa-an urgent research priority. N Engl J Med 2013, 368:886-889. 10.1056/NEJMp1300458, 23425131.
7. Nkengasong JN. A shifting paradigm in strengthening laboratory health systems for global health: acting now, acting collectively, but acting differently. Am J Clin Pathol 2010, 134:359-360. 10.1309/AJCPY5ASUEJYQ5RK, 20716789.
8. Clouse K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, Gay C, Sanne I, Fox MP. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2013, 62:e39-e46. 10.1097/QAI.0b013e318273ac48, 23011400.
9. Govender N, Chetty V, Roy M, Chiller TM, Oladoyinbo S, Maotoe T, Stevens WS, Pinini Z, Spencer D, Venter F, Jassat W, Cameron D, Meintjes G, Mbengashe T, Pillay Y. Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J 2012, 102:914-917. 10.7196/samj.6228, 23498036.
10. Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia de la Vega F, Perrin L, Rodriguez W. HIV viral load monitoring in resource-limited regions: optional or necessary?. Clin Infect Dis 2007, 44:128-134. 10.1086/510073, 17143828.
11. Rutherford GW, Anglemyer A, Easterbrook PJ, Horvath T, Vitoria M, Penazzato M, Doherty MC. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. AIDS 2014, 2:S161-S169. 10.1097/QAD.0000000000000236.
12. World Health Organization/UNITAID: HIV/AIDS Diagnostics Technology Landscape 2014 4th Edition, http://www.unitaid.eu/images/marketdynamics/publications/UNITAID-HIV_Diagnostic_Landscape-4th_edition.pdf
13. World Health Organization/UNITAID: HIV/AIDS: Diagnostic Technology landscape. Semi-annual update 2013, http://www.unitaid.org/images/UNITAID_2013_Semi-annual_Update_HIV_Diagnostics_Technology_Landscape.pdf
14. Gale HB, Gitterman SR, Hoffman HJ, Gordin FM, Benator DA, Labriola AM, Kan VL. Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts > =300 cells/uL and HIV-1 suppression?. Clin Infect Dis 2013, 56:1340-1343. 10.1093/cid/cit004, 23315315.
15. Mosen DM, Horberg M, Roblin D, Gullion CM, Meenan R, Leyden W, Hu W. Effect of once-daily FDC treatment era on initiation of cART. HIV AIDS (Auckl) 2010, 2:19-26.
16. World Health Organization: March 2014 Supplement to the 2013 Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV infection. http://www.who.int/hiv/pub/guidelines/arv2013/arvs2013upplement_march2014/en/
17. World Health Organization: Global Tuberculosis Report 2013. Country profiles. http://www.who.int/tb/publications/global_report/en/
18. Kost GJ. Point-of-care testing in intensive care, and planning and implementing point-of-care test systems. Principles and Practice of Intensive Care Monitoring 1998, 1267-1328. McGraw Hill, New York, NY, Tobin MA.
19. Zucker ML. Point of care testing guideline published by CLSI. Lab Medicine 2010, 41:499-500. 10.1309/LM22RU1RCUXZPRXN.
20. Kilgore ML, Steindel SJ, Smith JA. Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing. J Healthc Manag 1999, 44:207-215. 10537498.
21. Kost GJ, Ehrmeyer SS, Chernow B, Winkelman JW, Zaloga GP, Dellinger RP, Shirey T. The laboratory-clinical interface: point-of-care testing. Chest 1999, 115:1140-1154. 10.1378/chest.115.4.1140, 10208220.
22. Plebani M. Does POCT reduce the risk of error in laboratory testing?. Clin Chim Acta 2009, 404:59-64. 10.1016/j.cca.2009.03.014, 19298804.
23. Warsinke A. Point-of-care testing of proteins. Anal Bioanal Chem 2009, 393:1393-1405. 10.1007/s00216-008-2572-0, 19130044.
24. Hammett-Stabler CA, Nichols JH. Point-of-care testing, a critical component of laboratory medicine. Clin Biochem 2009, 42:135. 10.1016/j.clinbiochem.2008.09.097, 19167965.
25. Lewandrowski K. Point-of-care testing: an overview and a look to the future (circa 2009, United States). Clin Lab Med 2009, 29:421-432. 10.1016/j.cll.2009.06.015, 19840677.
26. Girardin CM, Huot C, Gonthier M, Delvin E. Continuous glucose monitoring: a review of biochemical perspectives and clinical use in type 1 diabetes. Clin Biochem 2009, 42:136-142. 10.1016/j.clinbiochem.2008.09.112, 18951887.
27. Sorger PK. Microfluidics closes in on point-of-care assays. Nat Biotechnol 2008, 26:1345-1346. 10.1038/nbt1208-1345, 19060870.
28. Kricka LJ. Microchips, microarrays, biochips and nanochips: personal laboratories for the 21st century. Clin Chim Acta 2001, 307:219-223. 10.1016/S0009-8981(01)00451-X, 11369361.
29. Alharbi KK, Al-Sheikh YA. Role and implications of nanodiagnostics in the changing trends of clinical diagnosis. Saudi J Biol Sci 2014, 21:109-117. 10.1016/j.sjbs.2013.11.001, 24600302.
30. Syed MA. Advances in nanodiagnostic techniques for microbial agents. Biosens Bioelectron 2014, 51:391-400. 10.1016/j.bios.2013.08.010, 24012709.
31. Jani IV, Peter T. How point-of-care testing could drive innovation in global health. New Engl J Med 2013, 368:2319-2324. 10.1056/NEJMsb1214197, 23758238.
32. Grand View Research: Report 2014: Point of Care Diagnostics (POC) Market Analysis By Product (Blood Gas/Electrolytes, Infectious Diseases, Hospital Glucose Testing, Cardiac Markers, Hematology, Coagulation, Primary Care Systems, Decentralized Clinical Chemistry, Urinalysis, Drug Abuse Testing, Fertility, OTC and Rapid Diagnostic Tests) And Segment Forecasts To 2020. http://www.grandviewresearch.com/industry-analysis/point-of-care-poc-diagnostics-industry
33. WHO Department of HIV/AIDS,UNAIDS: The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. Accessed August 2014.., www.who.int/hiv/pub/arv/treatment/en/
34. WHO: Consolidated guidelines on the use of antiretroviral drugs for treatment and prevention of HIV infection.. Accessed August 2014.., www.who.int/hiv/pub/guidelines/arv2013/en/
35. Fox MP, Shearer K, Maskew M, Macleod W, Majuba P, Macphail P, Sanne I. Treatment outcomes after 7 years of public-sector HIV treatment. AIDS 2012, 26:1823-1828. 10.1097/QAD.0b013e328357058a, 22739391.
36. WHO: Global Health Strategy on HIV/AIDS: 2011-2015.. Accessed August 2014.., www.who.int/hiv/pub/hiv_strategy/en/
37. Peeling RW, McNerney R. Emerging technologies in point-of-care molecular diagnostics for resource-limited settings. Expert Rev Mol Diagn 2014, 14:525-534. 10.1586/14737159.2014.915748, 24784765.
38. South African National Accreditation System: ISO Point-of-care testing (POCT) - requirements for quality and competence, in ISO 22870:2006200, http://www.iso.org/iso/catalogue_detail.htm?csnumber=35173
39. Scott L: An evaluation of the Liat assay (IQUUM). aslm.org/aslm2012/images/docs/Friday-December-7th-2012/Oral-Presentations/Point-of-Care%20Diagnostics%20-%20Evaluation%20Outcomes/3.%20lesley%20scott.pdf
40. Jani IV, Meggi B, Mabunda N, Vubil A, Sitoe NE, Tobaiwa O, Quevedo JI, Lehe JD, Loquiha O, Vojnov L, Peter TF. Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test. J Acquir Immune Defic Syndr 2014, 16:e1-e4. 10.1097/QAI.0000000000000250.
41. Lee H. Point of care HIV molecular tests: Bridging the gap between laboratory and patient. Presentation in 1st International Conference of the African Society for Laboratory Medicine: 2012 December 1-7; Cape Town, South Africa 2013, ASLM, Cape Town.
42. Logan C, Givens M, Ives JT, Delaney M, Lochhead MJ, Schooley RT, Benson CA. Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. J Immunol Methods 2013, 387:107-113. 10.1016/j.jim.2012.10.002, 23063690.
43. Bornheimer S, Bui N, Le D, Wai H, Tran A, Goldberg E, Bouic P, Huang W, Sugarman J, Crowe M, Kumar V, Shook J, Tomas C, Yu J, Clark A, Broszeit E, Chen R, Bush-Donovan C. Development of the BD FACSPresto instrument, a new point-of-care system for CD4+ counting. Poster presentation TUPE265 in 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention: 2013 June 30 - July 3, Kuala Lumpur 2013, International AIDS Society, Kuala Lumpur.
44. Murtagh M: Viral load: Current technologies and the pipeline, including point-of-care assays, http://www.aslm.org/?wpdmdl=95
45. Gandelman OA, Church VL, Moore CA, Kiddle G, Carne CA, Parmar S, Jalal H, Tisi LC, Murray JA. Novel bioluminescent quantitative detection of nucleic acid amplification in real-time. PLoS One 2010, 5:e14155. 10.1371/journal.pone.0014155, 21152399.
46. Laurence C, Gialamas A, Yelland L, Bubner T, Ryan P, Willson K, Glastonbury B, Gill J, Shephard M, Beilby J. A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics. Trials 2008, 9:50. 10.1186/1745-6215-9-50, 18681979.
47. Shephard MD, Mazzachi BC, Watkinson L, Shephard AK, Laurence C, Gialamas A, Bubner T. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices. Rural Remote Health 2009, 9:1189. 19689171.
48. Shephard MD. Influence of geography on the performance of quality control testing in the Australian Government's point of care testing in general practice trial. Clin Biochem 2009, 42:1325-1327. 10.1016/j.clinbiochem.2009.05.008, 19465017.
49. South African National Department of Health, National Health Laboratory Service: Point-of-care testing: Position paper Forum Report to support National Strategic Plan for POCT for the management of HIV and TB in South Africa: An overview of the Point-Of Care Forum hosted by the National Department of Health. 2013. In preparation..
50. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, Lehe JD, Peter TF. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 2011, 378:1572-1579. 10.1016/S0140-6736(11)61052-0, 21951656.
51. World Health Organization: Prequalification of diagnostics, http://www.who.int/topics/prequalification/en/
52. Benzaken AS, Bazzo ML, Galban E, Pinto IC, Nogueira CL, Golfetto L, Benzaken NS, Sollis KA, Mabey D, Peeling RW. External quality assurance with dried tube specimens (DTS) for point-of-care syphilis and HIV tests: experience in an indigenous populations screening programme in the Brazilian Amazon. Sex Transm Infect 2014, 90:14-18. 24031029.
53. Gous N, Cunningham B, Kana B, Stevens W, Scott LE. Performance monitoring of mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa. J Clin Microbiol 2013, 51:4018-4021. 10.1128/JCM.01715-13, 24068004.
54. Scott LE, Gous N, Cunningham BE, Kana BD, Perovic O, Erasmus L, Coetzee GJ, Koornhof H, Stevens W. Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J Clin Microbiol 2011, 49:4356-4360. 10.1128/JCM.05167-11, 21976767.
55. Cepheid: Remote connectivity. In Presentation in 5th Annual GLI Conference: 2013 April 15-18; Annecy, France. http://www.gxalert.com/index.php/presentation-at-the-5th-annual-gli-conference-in-annecy-france-april-15-18-2013/
56. Kessler HH, Jungkind D, Stelzl E, Direnzo S, Vellimedu SK, Pierer K, Santner B, Marth E. Evaluation of AMPLILINK software for the COBAS AMPLICOR system. J Clin Microbiol 1999, 37:436-437. 9889236.
57. St John A, Merkle H. A connectivity standard for point-of-care testing. Med Device Technol 2001, 12:23-26. 12938534.
58. Stevens W: Viral load testing in Africa - 23 years later. www.aslm.org/?wpdmdl=85
59. Faal M, Naidoo N, Glencross DK, Venter WD, Osih R. Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr 2011, 58:e54-e59. 10.1097/QAI.0b013e3182303921, 21857356.
60. Manyazewal T, Paterniti AD, Redfield RR, Marinucci F. Role of secondary level laboratories in strengthening quality at primary health care facilities' laboratories: an innovative approach to ensure accurate HIV, tuberculosis and malaria tests is resource-limited settings. Diagn Microbiol Infect Dis 2013, 75:55-59. 10.1016/j.diagmicrobio.2012.09.020, 23102548.
61. World Health Organization: The Maputo declaration on strengthening of laboratory systems 2008, http://www.who.int/diagnostics_laboratory/Maputo-Declaration_2008.pdf